• Breaking News

    Wednesday, February 3, 2021

    imminent growth of NASDAQ:INO. DNA vaccines for immunotherapy Investment Club

    imminent growth of NASDAQ:INO. DNA vaccines for immunotherapy Investment Club


    imminent growth of NASDAQ:INO. DNA vaccines for immunotherapy

    Posted: 03 Feb 2021 04:36 AM PST

    dear investors,

    NASDAQ:INO inovio is working on replacing cancer surgery by the use of therapeutic vaccines, and is very close to communicate broadly about its success. Inovio is focused on bringing to market DNA medicines to treat and protect people from infectious diseases and cancer.

    Many products in their pipeline are reaching phase 2 and 3 clinical trials with outstanding outcome. the results of this tech in fighting the most wide spread cancers and other life treaths are bound to be communicated properly.

    https://www.reddit.com/r/Inovio/comments/lbkbp5/vgx3100_has_been_defeating_hpv_cause_of_cancer/

    https://www.reddit.com/r/Inovio/comments/l9f5v6/inovios_amazing_lifesaving_pipeline/

    "The Inovio technology is based on inserting engineered DNA into cells where it becomes incorporated into proteins involved in the immune response to cancers and viruses by producing T cells and antibodies that aid recovery from infection. The technology can be targeted to specific types of cancer and immune diseases, such as those produced by a virus."

    The inovio vaccine pipeline will trigger a paradigm shift in medicine. on a side note, INO will most probably release a COVID vaccine this year. Short-term growth of INO will be fueled by INO-4800, a DNA vaccine candidate to protect against coronavirus :

    https://www.reddit.com/r/Inovio/comments/l6vg0z/why_inovio_deserves_a_200_plus_valuation/

    make no mistake : hedge funds, banks, and other big players have been scooping up INO shares on the cheap :

    "Inovio Pharmaceuticals, Inc. (US:INO) has 420 institutional owners and shareholders that have filed 13D/G or 13F forms with the Securities Exchange Commission (SEC). These institutions hold a total of 93,273,893 shares. Largest shareholders include BlackRock Inc., Vanguard Group Inc, State Street Corp, XBI - SPDR(R) S&P(R) Biotech ETF, VTSMX - Vanguard Total Stock Market Index Fund Investor Shares, Coatue Management Llc, Wasatch Advisors Inc, IWM - iShares Russell 2000 ETF, Jane Street Group, Llc, and Geode Capital Management, Llc."

    https://fintel.io/so/us/ino

    while citron research told all the retail traders to avoid this stock :

    https://mobile.twitter.com/citronresearch/status/1263113649935155200?lang=en

    which has led to massive short interest. Adjusted for institutional holdings, the free float net short position is approx 50 %, which makes INO a top shorted stock :

    https://shortsqueeze.com//shortinterest/stock/term2.php?s=INO

    which in turn has prevented the development of the company :

    https://www.reddit.com/r/Inovio/comments/l8fkpw/the_corruption_against_ino/

    a good place to start your own research is this sub :

    r/Inovio

    to educate yourself about the reasons why we will see tremendous growth of NASDAQ:INO in the very near future.

    submitted by /u/faintingoat
    [link] [comments]

    $LUMN Intrinsic Value $24 - $35

    Posted: 02 Feb 2021 04:56 PM PST

    $LUMN Intrinsic Value $24 - $35

    YES $LUNM will go up!

    Intrinsic value of Lumen (LUMN) with possible 10X return. Last time I tell you chumps about this one. Look, I know everyone here only cares about high tech meme stocks valued at 10X the entire market for their shitty products. But if you have the tiniest amount of patience there might be an opportunity with limited downside to capitalize on a severely undervalued company according to many analysts including Michael Burry, the autist from The Big Short.

    Here are some choice quotes from The Investors Podcast (linked below):

    "So our premise really is that as long as people wake up to the fact that the core assets of Level 3 are worth what they are worth in the private market for, let's say, around $34 billion. And as long as people apply even some modicum of multiple to the remaining CenturyLink assets, you have a completely insane risk reward from $9.50 or whatever it's trading at today. So that's kind of some of the parts we look at how to value or approach value in the company. And again for us, it's more about margin of safety. So our margin of safety really is that, look, if someone offered me $1.7 billion in cash flow today, and I only have to pay 10 billion to get it, I would take that bet. That's it in a nutshell."

    There is also a rumor that the company might split its two businesses to capitalize on the multiple that its Level 3 infrastructure should be receiving: "I mentioned that we have this hypothesis that the company's in the middle of splitting these two companies up and it's messy. This was a messy merger. There are a lot of physical assets. There are little things that you have to figure out transfer pricing in between if you sell your fiber assets, if the company split the split off company is still using the fiber assets, you have to figure out transfer pricing. And so I'm not saying it's simple, but given this is a company that people know, Seattle Seahawks Stadium is a CenturyLink field, right? And so this is a company people know, we have a CEO who is highly incentivized to create value for shareholders who's done it before. And one more point, you go to their June, 2020 presentation for the first time we'd ever seen, they put in a slide that said, "Hey, we know we have a $10 stock, but here are some appropriate multiples we have for our two businesses."

    The estimate is $24-25 valuation based on a 4-5X fair multiple of EBITDA for this company: "Hey, so you have three billion in EBITDA here at Level 3, you have six billion EBITDA at CenturyLink, let's put just conservative multiples on those illustrative of what these companies could be worth." And so this is a company that had a $10 stock that was saying, "We think we're worth 24 to 35." I mean, these are numbers that you almost don't put out there because people think that's so crazy."

    And maybe they are crazy. But options are so darn cheap that in my non-investment advice giving opinion its worth a flyer. There are two possible catalysts coming (1) announcement of splitting two companies up or (2) just outperforming expectations in Q1, which management is already on track to doing. The company has already consolidated debt significantly in the last year. Institutions own 79.6% of the stock, up 1.9% this quarter.

    Unlike you retards I can 💎👐 this straight through expiry. I have patience and I want to be ahead of the game. When you come fashionably late to the memestock party you just get dumped on. Patience. As Warren Buffet said "the money is made in the waiting."

    🕑 🕑 🚀🚀🚀🚀🚀

    Positions: 4/21 400 $13c, 6/21 80 $12.50c, 1/22 100 $15c and various leaps.

    Get rich or die stupid!!!

    Source: https://youtu.be/RoVmNfB26gc (8 mins) https://youtu.be/wzPAHXkX6tM (1 hour) Transcript https://www.theinvestorspodcast.com/episodes/tip326-intrinsic-value-of-lumen-with-ben-claremon-and-eugene-robin/

    submitted by /u/Academic-Aside-9088
    [link] [comments]

    What's your opinion on my option play?

    Posted: 02 Feb 2021 05:12 PM PST

    Wanted to get some feedback on my options play. I bought 1 call of Nio. Strike price is 54. Expires 2/12/2021.

    I wanted to get some feedback since I'm still learning and buying affordable Options to continue learning. I bought it because it went down a bit and I think it's going to go back soon. Thank you in advance!

    submitted by /u/The0Walrus
    [link] [comments]

    Why's NVAX skyrocketing, when AZN, PFE didn't skyrocket?

    Posted: 01 Feb 2021 07:50 PM PST

    I'm new to investing and I'm not a virologist. If I understand, AZN, MRNA, NVAX, PFE's vaccines all had >80% high efficacy rates in Phase III trials. But AZN's and PFE's share prices didn't skyrocket like NVAX is skyrocketing now. I don't know how to assess if MRNA skyrocketed?

    I'm guessing because MRNA and NVAX have smaller market caps? Any other reason?

    submitted by /u/c1p_3
    [link] [comments]

    No comments:

    Post a Comment